Oxygen free radicals and excitation-contraction coupling
Reactivation of oxidized PTP1B and PTEN by thioredoxin 1
Anthony shares what this looked like in his own life: the ADHD medication he didn't fully disclose, the secrets he was keeping while standing in recovery spaces, the chest-weight of maintaining a sober identity when the reality was far messier
doi: 10.1007/s12020-015-0788-2 84 FerraraRIentileVArcoraciVFerrajoloCPiccinniCFontanaAet al
Patrick Kee, MD, PhD, a cardiologist at Vital Heart & Vein, who was not involved in the study, noted the following about the studys results: The investigators demonstrated that the therapeutic efficacy of semaglutide on the primary cardiovascular composite endpoint indeed emerged early and persisted over the initial three months (hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.41-0.95) and the subsequent six months (HR 0.60, 95% CI 0.44-0.81). While the underlying mechanisms of semaglutides early clinical benefits remain under investigation, these findings suggest an encouraging intervention capable of altering the trajectory of [patients with obesity] with established cardiovascular disease but without a diagnosis of diabetes, he told Medical News Today
